Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-06-16

FDA Approved: RUFINAMIDE — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved Aurobindo Pharma Limited's original ANDA for a generic Rufinamide product, intended for seizures associated with Lennox-Gastaut syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rufinamide (Rufinamide)

Snippet

ORIG AP for RUFINAMIDE (RUFINAMIDE)